WallStreetZenWallStreetZen

NASDAQ: BLTE
Belite Bio Inc Stock

$45.80-0.35 (-0.76%)
Updated Feb 28, 2024
BLTE Price
$45.80
Fair Value Price
$2.06
Market Cap
$1.14B
52 Week Low
$11.00
52 Week High
$48.60
P/E
-72.7x
P/B
27.48x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$12.65M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.07
Operating Cash Flow
-$11M
Beta
-0.06
Next Earnings
Mar 29, 2024
Ex-Dividend
N/A
Next Dividend
N/A

BLTE Overview

Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company. The company's pipeline of therapies is built on its RBP4 (Retinol Binding Protein 4) IP portfolio. Belite Bio is focused on meeting the unmet needs of patients suffering from blindness, liver disease, and diabetes. The company operates as a subsidiary of Lin Bioscience International Ltd. Belite Bio was founded in 2016 and is based in San Diego, CA.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BLTE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BLTE ($45.80) is overvalued by 2,119.46% relative to our estimate of its Fair Value price of $2.06 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
BLTE ($45.80) is not significantly undervalued (2,119.46%) relative to our estimate of its Fair Value price of $2.06 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
BLTE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more BLTE due diligence checks available for Premium users.

Be the first to know about important BLTE news, forecast changes, insider trades & much more!

BLTE News

Valuation

BLTE fair value

Fair Value of BLTE stock based on Discounted Cash Flow (DCF)
Price
$45.80
Fair Value
$2.06
Overvalued by
2,119.46%
BLTE ($45.80) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BLTE ($45.80) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BLTE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BLTE price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-72.7x
Industry
13.96x
Market
35.52x

BLTE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
27.48x
Industry
6.14x
BLTE is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BLTE's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
BLTE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$44.3M
Liabilities
$2.8M
Debt to equity
0.07
BLTE's short-term assets ($42.81M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BLTE's short-term assets ($42.81M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BLTE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
BLTE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

BLTE vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
BLTE$1.14B-0.76%-72.70x27.48x
RNA$1.13B-0.33%-5.09x2.19x
TNGX$1.17B-2.46%-10.37x4.24x
BCYC$1.11B-0.46%-5.11x2.98x
BCRX$1.18B-2.73%-4.84x-2.58x

Belite Bio Stock FAQ

What is Belite Bio's quote symbol?

(NASDAQ: BLTE) Belite Bio trades on the NASDAQ under the ticker symbol BLTE. Belite Bio stock quotes can also be displayed as NASDAQ: BLTE.

If you're new to stock investing, here's how to buy Belite Bio stock.

What is the 52 week high and low for Belite Bio (NASDAQ: BLTE)?

(NASDAQ: BLTE) Belite Bio's 52-week high was $48.60, and its 52-week low was $11.00. It is currently -5.76% from its 52-week high and 316.36% from its 52-week low.

How much is Belite Bio stock worth today?

(NASDAQ: BLTE) Belite Bio currently has 24,898,908 outstanding shares. With Belite Bio stock trading at $45.80 per share, the total value of Belite Bio stock (market capitalization) is $1.14B.

Belite Bio stock was originally listed at a price of $10.59 in Apr 29, 2022. If you had invested in Belite Bio stock at $10.59, your return over the last 1 years would have been 332.48%, for an annualized return of 332.48% (not including any dividends or dividend reinvestments).

How much is Belite Bio's stock price per share?

(NASDAQ: BLTE) Belite Bio stock price per share is $45.80 today (as of Feb 28, 2024).

What is Belite Bio's Market Cap?

(NASDAQ: BLTE) Belite Bio's market cap is $1.14B, as of Feb 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Belite Bio's market cap is calculated by multiplying BLTE's current stock price of $45.80 by BLTE's total outstanding shares of 24,898,908.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.